Inflammatory Bowel Diseases
Publication Venue For
Tofacitinib Treatment Safety in Moderate to Severe Ulcerative Colitis: Comparison of Observational Population Cohort Data from the IBM MarketScan® Administrative Claims Database with Tofacitinib Trial Data
Challenges in IBD Research: Pragmatic Clinical Research
Challenges in IBD Research: Preclinical Human IBD Mechanisms
Improved Quality of Life with Anti-TNF Therapy Compared with Continued Corticosteroid Utilization in Crohn's Disease
Abdominal pain and the neurotrophic system in ulcerative colitis
Comparison of multiple enzyme activatable near-infrared fluorescent molecular probes for detection and quantification of inflammation in murine colitis models
Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease
Linking vitamin D deficiency to inflammatory bowel disease
Fluorescence endoscopy of cathepsin activity discriminates dysplasia from colitis.
HMPL-004 (Andrographis paniculata extract) prevents development of murine colitis by inhibiting T-cell proliferation and T
Independent replication of an association of CNVR7113.6 with Crohn's disease in caucasians
Innate dysfunction promotes linear growth failure in pediatric Crohn's disease and growth hormone resistance in murine ileitis
Differential association of two PTPN22 coding variants with Crohn's disease and ulcerative colitis
Impact of capsule endoscopy on management of inflammatory bowel disease: A single tertiary care center experience
Association of the protein-tyrosine phosphatase nonreceptor type substrate 1 (PTPNS1) gene with inflammatory bowel disease
Association of FcgR2a, but not FcgR3a, with inflammatory bowel diseases across three Caucasian populations
Differential susceptibility of P-glycoprotein deficient mice to colitis induction by environmental insults
Enhanced CBir1-specific innate and adaptive immune responses in Crohn's disease
Therapeutic benefit of pentostatin in severe IL-10-/- colitis.
III. Report of adaptive and regulatory immune responses workgroup
X. Challenges update workgroups
Isolation of flagellated bacteria implicated in Crohn's disease
Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations
CCFA microbial-host interactions workshop: Highlights and key observations
CCFA host-microbial interactions workshop: highlights and key observations
Anti-interferon-inducible chemokine, CXCL10, reduces colitis by impairing T helper-1 induction and recruitment in mice.
Gene disruption and immunity in experimental colitis
Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs
Regulation of gene expression in inflammatory bowel disease and correlation with IBD drugs: screening by DNA microarrays.
Challenges in IBD research: Updating the scientific agendas
Heritable susceptibility for colitis in mice induced by IL-10 deficiency
Controversies in pediatric inflammatory bowel disease
Why doesn't cyclosporine work in Crohn's disease?
The effect of immunosuppressive agents on monocyte generation and cytokine expression
International Standard Serial Number (issn)
Electronic International Standard Serial Number (eissn)